[ Price : $8.95]
Two drug company stakeholders respond to an FDA draft guidance on Orange Book questions and answers.[ Price : $8.95]
Attorney Jeffrey Shapiro discusses reasons why HHS made the right decision in ordering FDA to abstain from the premarket review of...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Acella Pharmaceuticals, Mylan and Revival Products.[ Price : $8.95]
An assessment finds that combination product review practices are generally efficient and effective and need only minor adjustment...[ Price : $8.95]
The Justice Department says the former Indivior global medical director has pleaded guilty to a single misdemeanor charge of intro...[ Price : $8.95]
FDA issues a guidance to help manufacturers prevent unacceptable levels of nitrosamines in all chemically synthesized drugs.[ Price : $8.95]
Scripps Research Translational Institute director Eric Topol writes an open letter to FDA commissioner Stephen Hahn asking him to ...[ Price : $8.95]
Twenty-three attorneys general ask FDA not to allow branded drug companies to list device and component patents in the Orange Book...